For Healthcare Professionals: Blood & Marrow Stem Cell Transplantation

Our program in bone and marrow stem cell transplantation is one of the largest and most established nationwide. Since performing the first successful stem cell transplant between a patient and an unrelated donor in the early 1970s, we have remained pioneering and productive in the field, carrying out more than 4,000 autologous and allogeneic transplants and introducing approaches now commonly used around the globe. Advances we have helped to develop include T cell depletion, hyperfractionated irradiation, and methods to prevent graft-versus-host disease.

Referring a Patient

Call 877-836-ABMT (2268)
Mon–Fri, 8:30 AM–5:30 PM, ET

Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Pictured: Esperanza Papadopoulos
Adult Blood & Marrow Stem Cell Transplantation Information for Your Patients  

The Memorial Sloan Kettering approach to adult stem cell transplantation in patient-friendly language.

Pictured: Richard O'Reilly
Pediatric Blood & Marrow Transplantation Information for Your Patients

The Memorial Sloan Kettering approach to pediatric blood and marrow transplantation in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Guenther Koehne
Treating CMV Reactivation Following Allogeneic Bone Marrow Transplant

Physician-scientist Guenther Koehne, Medical Director of the Cytotherapy Laboratory, explains a therapy that uses sensitized T cells to treat resistant CMV infection in allogeneic stem cell transplant recipients.

Pictured: Miguel Angel Perales
IL-7 Promotes T Cell Recovery after Allogeneic Stem Cell Transplantation

Medical oncologists Marcel van den Brink and Miguel-Angel Perales describe results of a phase I trial of IL-7 in stem cell transplantation.

Pictured: Robert Jenq
Regulation of Intestinal Inflammation by Microbiota following Allogeneic Bone Marrow Transplantation

Medical oncologist Robert Jenq describes the role of microbiota in regulating intestinal inflammation post-allogeneic bone marrow transplant.

Pictured: Guenther Koehne
CMV Reactivation
Pictured: Miguel Angel Perales
IL-7 & T Cell Recovery
Pictured: Robert Jenq